Status:
COMPLETED
Investigating CBF and ICP Using DCS
Lead Sponsor:
Queen Mary University of London
Collaborating Sponsors:
Barts & The London NHS Trust
Conditions:
Traumatic Brain Injury
Intracranial Hypertension
Eligibility:
All Genders
16+ years
Brief Summary
We aim to acquire data using DCS on patients who are undergoing invasive ICP and ABP monitoring on ITU as part of their normal treatment. Data will then be correlated to derive various parameters inc...
Detailed Description
Cerebral Autoregulation (CA) is the complex process whereby the body maintains constant blood flow to the brain (cerebral blood flow, CBF) over a wide range of mean arterial pressures (MAP) in order t...
Eligibility Criteria
Inclusion
- Invasive monitoring of ICP and ABP as part of normal treatment
Exclusion
- Not meeting inclusion criteria.
Key Trial Info
Start Date :
January 5 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 20 2023
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT06039098
Start Date
January 5 2023
End Date
August 20 2023
Last Update
February 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal London Hospital
London, United Kingdom